Does DASATINIB Cause Thrombotic microangiopathy? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Thrombotic microangiopathy have been filed in association with DASATINIB (dasatinib). This represents 0.1% of all adverse event reports for DASATINIB.
19
Reports of Thrombotic microangiopathy with DASATINIB
0.1%
of all DASATINIB reports
7
Deaths
5
Hospitalizations
How Dangerous Is Thrombotic microangiopathy From DASATINIB?
Of the 19 reports, 7 (36.8%) resulted in death, 5 (26.3%) required hospitalization.
Is Thrombotic microangiopathy Listed in the Official Label?
Yes, Thrombotic microangiopathy is listed as a known adverse reaction in the official FDA drug label for DASATINIB.
What Other Side Effects Does DASATINIB Cause?
Pleural effusion (2,424)
Fatigue (2,173)
Death (1,741)
Nausea (1,740)
Diarrhoea (1,728)
Headache (1,625)
Adverse event (1,382)
Rash (1,300)
Drug ineffective (1,271)
Hospitalisation (1,181)
What Other Drugs Cause Thrombotic microangiopathy?
TACROLIMUS (1,982)
MYCOPHENOLATE MOFETIL (820)
CYCLOSPORINE (724)
GEMCITABINE (648)
ECULIZUMAB (636)
CYCLOPHOSPHAMIDE (602)
FLUDARABINE (480)
METHOTREXATE (447)
CARFILZOMIB (350)
METHYLPREDNISOLONE (345)
Which DASATINIB Alternatives Have Lower Thrombotic microangiopathy Risk?
DASATINIB vs DATOPOTAMAB DERUXTECAN-DLNK
DASATINIB vs DAUNORUBICIN
DASATINIB vs DAXIBOTULINUMTOXIN A-LANM
DASATINIB vs DAYTRANA
DASATINIB vs DECITABINE